Brueske Advisory Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,873
Closed -$347K 33
2025
Q3
$347K Buy
1,873
+93
+5% +$15.9K 0.19% 48
2025
Q2
$272K Sell
1,780
-18
-1% -$2.77K 0.18% 53
2025
Q1
$298K Buy
1,798
+61
+4% +$9.54K 0.28% 45
2024
Q4
$251K Buy
+1,737
New +$269K 0.22% 47

Other funds holding JNJ

Brueske Advisory Services's JNJ Position: Q4 2025 in Review

Brueske Advisory Services sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 1,873 shares — an estimated $347K sold.

Brueske Advisory Services first reported a position in JNJ in Q4 2024 and held it in 4 quarters. The position peaked at $347K in Q3 2025. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Brueske Advisory Services reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Brueske Advisory Services sold 1,873 Johnson & Johnson shares in Q4 2025, an estimated $347K.
  • Brueske Advisory Services first reported a position in Johnson & Johnson in Q4 2024 and held it in 4 quarters.
  • Brueske Advisory Services's Johnson & Johnson position peaked at $347K in Q3 2025.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Brueske Advisory Services's 13F filing for Q4 2025.